Cantor Fitzgerald analyst Pablo Zuanic maintains Canopy Gwth (TSX:WEED) with a Neutral and lowers the price target from C$6.75 to C$3.75.
Why Protagonist Therapeutics Shares Are Nosediving
Protagonist Therapeutics Inc (NASDAQ: PTGX) shares are trading lower by 9.68% to $19.46 Wednesday morning after the company announced pricing of a $100 million public offering of shares of common stock.
What Else?